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Many interventions demonstrate success in adapting the duration of intravenous antibiotic
therapy, but few studies have been conducted in developing countries. The aim of this study
was  to evaluate the effectiveness of an intervention in the induction of early discontinuation
of  intravenous antimicrobial therapy and/or its switch to oral therapy. The study employed
a  before–after intervention design that consisted of displaying a message in the comput-
erized prescription on the third day and suspension of the prescription on the ﬁfth day of
intravenous antimicrobial therapy. A total of 465 patients were followed during the control
period (CP) and 440 in the intervention period (IP). The intravenous therapy was switched
to  oral therapy for 11 (2.4%) patients during the CP and 25 (5.7%) in the IP (p = 0.011), and
was  discontinued for 82 (17.6%) patients during the CP and 106 (24.1%) in the IP (p = 0.017).
During the IP there was a signiﬁcant increase of patients who had their antimicrobial treat-
ment discontinued before the seventh day of intravenous treatment, 37.40% (49/131) in the
IP  and 16.13% (15/93) in the CP (p = 0.0005). The duration of intravenous antimicrobial therapy
decreased by one day, but it was not signiﬁcant (p = 0.136). It is concluded that the proposed
intervention is effective in promoting the early discontinuation of antimicrobial treatment
and/or switch to oral therapy. As long as a computerized system for prescription already
exists, it is easy and inexpensive to be implemented, especially in hospitals in developingcountries.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/∗ Corresponding author.
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ntroduction
part from causing therapeutic injury and unnecessary
oxicity to the patient, the frequent use of inappropri-
te antimicrobials found in hospitals1–5 generates increased
osts and has a great impact on bacterial resistance.6 The
mplementation of programs aiming to improve the use of
ntibiotics in hospitals is widely recommended, especially in
eveloping countries.7 However, problems such as scarcity of
nancial resources and poor infrastructure, deﬁciency of spe-
ialized training, lack of control over the supply and quality of
ntibiotics, poor hygiene, overcrowding, and cultural habits of
hysicians and patients hinder the implementation of these
rograms in developing countries.8,9
In Brazil and other developing countries, the availability
nd use of antimicrobials are poorly controlled, which further
ggravates the problem of bacterial resistance.10 On the other
and, because the public Uniﬁed Health System (SUS – Sistema
niﬁcado de Saúde)  is universal and free, health authorities are
oncerned with the proper use of antibiotics.11–13
Reassessment of antimicrobial therapy by the third day is a
ecommended measure in antimicrobial stewardship. At this
ime, the identiﬁcation of microorganisms and their suscep-
ibility allow targeted therapy, and clinical evaluation of the
atient may lead to discontinuation, change in therapy dura-
ion, and/or switch to oral therapy.14–17 Doctors have often
gnored this revaluation due to several factors such as time
onstraint, change of the physician responsible for the patient
uring the ﬁrst days of hospitalization, reluctance to change
he empirical therapy in a patient who has shown satisfactory
mprovement, or even due to poor education.18
When correctly recommended, the switch from intra-
enous to oral therapy reduces the potential for complications
ue to the use of intravenous devices, the length of hospi-
al stay, and hospital costs with the treatment.19,20Among
he criteria for switching to oral therapy are improvement of
linical and hemodynamic status, ability to ingest drugs, and
ormal gastrointestinal function.21–23
A wide range of interventions with contributions by clinical
harmacists is described in the literature and demonstrating
uccess in improving the prescription of antibiotics in hos-
italized patients, especially in inducing the switch to oral
herapy and decreased duration of intravenous therapy.24–28
owever, few studies have been conducted in developing
ountries and there is relatively little knowledge on effective
trategies to improve antimicrobial use in this context.7 The
im of this study was to evaluate the effectiveness of an easy
o implement intervention in the induction of early discontin-
ation of intravenous antimicrobial therapy and/or its switch
o oral therapy.
ethods
he present study adopted the historically controlled prospec-
ive model under the before and after an intervention type. It
as conducted at the Clinical Hospital of the Federal Univer-
ity of Uberlândia (HCU, Hospital de Clínicas de Uberlândia), a
ublic tertiary teaching hospital, holding 525 beds and entirely6;2 0(5):462–467 463
dedicated to SUS. The project for this study was approved
by the Research Ethics Committee of the Federal University
of Uberlândia (UFU, Universidade Federal de Uberlândia)  under
process number 379 467.
The HCU has a computerized prescription system that
allows the exchange of information between the physician,
clinical pharmacies, and the Hospital Infection Control Com-
mission (CCIH, Comissão de Controle de Infecc¸ão Hospitalar).
Among other functions, the system provides a daily list of
patients who are initiating treatment with antimicrobials and
only allows the prescription of these drugs when the physi-
cian ﬁlls in an “antimicrobial request form” in the system,
justifying the need for its use.
Data collection and evaluations of the medical prescrip-
tions and “antimicrobial request forms” were carried out by
two researchers, a pharmacist and an infectious disease physi-
cian at the Hospital Infection Control Service (SCIH, Servic¸o de
Controle de Infecc¸ão Hospitalar),  in the control period (CP) – Octo-
ber and November 2013 – and in the intervention period (IP) –
August and September 2014. The same methodology for data
collection was used in both periods. All patients who initiated
intravenous antibiotics during hospitalization in the 301 beds
of the Medical and Surgical wards, in the adult Intensive Care
Unit (ICU), and in the Emergency Room were consecutively
followed until discharge, death, or for 60 days.
Patients who were already using intravenous antimicrobial
on the ﬁrst day of the study and those who were discharged or
died in the ﬁrst three days of intravenous antimicrobial ther-
apy were excluded from evaluation. Patients who  had their
intravenous antimicrobial therapy discontinued or switched
to oral before the third day of treatment were also excluded.
Intervention
Intervention consisted of messages on the patient’s electronic
prescription by the third day of intravenous treatment and
suspension of antimicrobial prescribing by the ﬁfth day of
intravenous treatment. The physicians saw the message only
on the fourth day of treatment, upon a new prescription. It
pointed to the evaluation of possible appropriateness (tar-
geted therapy), discontinuation of the antimicrobial treatment
or switch to oral therapy in case the patient was hemody-
namically stable, afebrile, presented clinical and leukocyte
count improvement, and was able to ingest and/or absorb the
antimicrobial. In case the third day of intravenous antimi-
crobial therapy occurred over the weekend or holiday, the
message was displayed on the following business day.
Suspension of the antimicrobials prescription of by the
pharmaceutical researcher was only conducted on the ﬁfth
day of treatment with intravenous antimicrobial. The sus-
pension took into account predetermined criteria based on
national and international protocols and data available on
the local antimicrobial resistance. When necessary, the treat-
ing physicians were contacted by telephone for clariﬁcation
of the patients’ condition. To continue prescribing the sus-
pended intravenous antimicrobial, the physician in charge
for the patient had to ﬁll in a computerized form justify-
ing the continuation of the treatment. In case the ﬁfth day
of the injectable antimicrobial treatment occurred over the
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Table 1 – Characteristics of the assessed patients and
classes of commonly used antimicrobials in the control
period (CP) and intervention period (IP).
CP IP p-value
Ward/Hospital – No. (%)
Surgical ward 102 (21.9%) 82 (18.6%) 0.2448a
Adult ICU 52 (11.2%) 40 (9.1%)
General medical ward 25 (5.4%) 19 (4.3%)
Emergency room 286 (61.5%) 299 (68.0%)
Likely source of infection – No. (%)
Urinary tract infection 109 (23.4%) 85 (19.3%) 0.0551a
Respiratory tract
infection
84  (18.1%) 99 (22.5%)
Intra-abdominal
infection
82 (17.6%) 73 (16.6%)
Skin and soft tissue
infection
61  (13.1%) 53 (12%)
Infection of the
osteoarticular system
56 (12%) 63 (14.3%)
Central nervous system
infection
10  (2.2%) 11 (2.5%)
Sepsis 56 (12.1%) 38 (8.7%)
Prophylaxis 7 (1.5%) 18 (4.1%)
Total 465 (100%) 440 (100%)
Classes of antimicrobials – No. (%)
Beta-lactams
Cephalosporins 466 (32.9%) 355 (29.2%) 0.0389c
Penicillinsb 160 (11.3%) 204 (16.8%) <0.0001c
Carbapenems 148 (10.5%) 112 (9.2%) 0.284118
Glycopeptides 150 (10.6%) 138 (11.3%) 0.540815
Nitroimidazole 115 (8.1%) 77 (6.3%) 0.077461
Quinolones 11 (7.8%) 114 (9.4%) 0.161931
Antifungals 90 (6.4%) 67 (5.5%) 0.358115
Lincosamides 79 (5.6%) 73 (6%) 0.645597
Sulfonamides 27 (1.9%) 27 (2.2%) 0.573581
Aminoglycosides 20 (1.4%) 17 (1.4%) 0.973036
Others 50 (3.5%) 33 (2.7%) 0.230188
Total 1416 1217
a Pearson’s chi-square test.
b Beta-lactams associated with beta-lactamase inhibitor are
included in the penicillin class.
c Signiﬁcance level (p < 0.05) based on the binomial test for compar-464  b r a z j i n f e c t d 
weekend or holiday, suspension of the prescription was made
on the following business day.
Outcomes
The frequency of premature discontinuation of intravenous
antimicrobial therapy or switch to oral therapy were consid-
ered as primary outcome, and the reduction in duration of
intravenous therapy and of hospital stay as secondary out-
comes. To evaluate safety and efﬁcacy of the antimicrobial
treatment the following were considered: need to resume
intravenous antimicrobial therapy, mortality, and readmis-
sions over a period of 60 days following patient’s hospital
discharge.
Statistical  analysis
Statistical analysis of the data was performed with the help
of JMP® software (SAS Institute, 1995). Because the data were
not normally distributed, as veriﬁed by the Shapiro–Wilk test
at 5% signiﬁcance level, differences between the medians of
hospital stay and duration of intravenous therapy in days were
evaluated using the non-parametric Mann–Whitney test.
The Pearson’s chi-square test was applied to evaluate the
potential association between categorical variables assessed
in the two  study periods (CP and IP). The binomial test for
comparing two proportions was applied for non-categorical
variables. A level of 5% signiﬁcance was considered.
The following outcomes were considered in data analy-
sis: switch to oral therapy when it occurred by the ﬁfteenth
day of intravenous antimicrobial treatment; discontinuation
of intravenous antimicrobial therapy without switching to
oral therapy, when all antimicrobials used were discontin-
ued before the ﬁfteenth day of use and the patient remained
hospitalized; maintenance of intravenous treatment until dis-
charge, when intravenous antimicrobial therapy was used
throughout the hospital stay. The patient’s length of hospital
stay was considered from the ﬁrst day intravenous antimi-
crobial were prescribed until discharge, death, or 60 days of
hospitalization.
Results
The study included 465 patients in the CP and 440 patients
in the IP. The patients’ mean age in years was similar in both
study periods, 48 ± 23.69 years in the CP and 48 ± 23.74 in the IP
(p = 0.9253). In the CP, 264 patients were male (56.8%) compared
to 282 (64.1%) in the IP (p = 0.0271). Clinical features, wards, and
the most commonly used classes of antimicrobials in both CP
and IP are shown in Table 1.
The median patients’ length of hospital stay was 11 days
in the CP (interquartile range 6 and 21.5 days) similar to the
IP (11; 7 and 21 days) [p = 0.8853]. The duration of intravenous
therapy was one day lower in the IP (median: 9; interquar-
tile range 6 and 17 days) compared to the CP (median: 10;
interquartile range 6 and 18 days), a non signiﬁcant differ-
ence (p = 0.1360). The proportion of readmitted patients was
signiﬁcantly higher in the IP (11.6%) compared to the CP (7.1%)ison of proportions.
[p = 0.0199]. However, there was no signiﬁcant difference in
patients who switched to oral therapy, 9.1% (1/11) in the CP and
8% (2/25) in the IP (p = 0.9131). The same occurred in patients
who had their intravenous antimicrobial treatment discon-
tinued, 10.98% (9/82) in the CP and 10.38% (11/106) in the IP
[p = 0.8950]. A total of 19.51% (16/82) of the patients had to
resume intravenous antibiotics in CP and 22.64% (24/106) in
the IP [p = 0.6031]. Twenty-seven percent (3/11) of the patients
resumed intravenous antibiotics after switching to oral ther-
apy in the CP and 20% (5/25) in the IP [p = 0.6287].
There was no difference in the percentage of patients who
used other oral medications concomitantly with intravenous
antimicrobials in both periods, 361 patients (77.6%) in the CP
and 325 (73.9%) in the IP (p = 0.1856).The intervention was associated with a signiﬁcant increase
in the number of patients who had their intravenous antimi-
crobial therapy stopped either by switching to oral therapy
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Table 2 – Frequency and type of changes in the
antimicrobial intravenous treatment in patients
evaluated during the control period (CP) and intervening
period (IP).
CP IP p-value
Variable – No. (%)
Switch to oral therapy 11 (2.37%) 25 (5.68%) 0.0107a
Discontinuation of
intravenous
treatment without
switching to oral
therapy
82  (17.63%) 106 (24.09%) 0.0167a
Maintenance of
intravenous
treatment until day of
discharge
372 (80.0%) 309 (70.23%) 0.0007a
Total 465 (100%) 440 (100%)
Discontinuation of
intravenous
treatment before the
seventh day of
antimicrobial
therapyb
15 (16.13%) 49 (37.40%) 0.0005a
Totalc 93 (100%) 131 (100%)
a Signiﬁcance level (p < 0.05) based on the binomial test for compar-
ison of proportions.
b Discontinuation of intravenous antimicrobial treatment before
the seventh day, either due to switch to oral therapy or discontin-
uation of treatment without switching to oral therapy.
c Total number of patients who had their intravenous antimicrobial
therapy discontinued, either due to switching to oral therapy or
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r by discontinuation without switching to oral therapy. The
ntervention was also associated with a signiﬁcant increase in
he number of patients who had their intravenous antimicro-
ial therapy discontinued before the seventh day (Table 2).
iscussion
he results indicate that the tested intervention was effec-
ive, since it led to a signiﬁcant increase in the number of
atients who had their intravenous antimicrobial therapy
topped by switching to oral therapy or by having the treat-
ent discontinued without switching to oral therapy. The
esults also indicate that the number of patients who had their
ntravenous antimicrobial treatment discontinued before the
eventh day increased signiﬁcantly by 21.27% during the inter-
ention.
The signiﬁcant increase in switching to oral therapy was
ess than impressive (3%). This percentage is much lower than
hat found in other studies conducted in other parts of the
orld.24,25,28 The low switching frequency to oral therapy in
he HCU was already known.29 This study does not add to the
nderstanding of this fact. This may occur due to organiza-
ional problems and medical practice, which could be reduced
y educational intervention or structural changes. Further-
ore, since the study design was not intended to follow
atients after their discharge, the number of patients who had6;2 0(5):462–467 465
their antimicrobial therapy switched to oral therapy may have
been underestimated. In the HCU, as well as in other Brazilian
hospitals, problems such as overcrowding and waiting lists for
admission encourage early discharge of patients.30 It is likely
that as soon as the hospitalized patient can stop the treat-
ment with intravenous antimicrobials or use it orally, he or
she is discharged and oral therapy is started at home.
Among the criteria for switching to oral therapy are the
ability to ingest drugs and the normal gastrointestinal func-
tion. Since in the two periods of the study most of the patients
were using oral drugs from other pharmacological groups
concomitantly with intravenous antibiotics, these patients
probably did not have gastrointestinal intolerance, thus able
to ingest and absorb oral antibiotics. Therefore, by hypothe-
sis, gastrointestinal intolerance must not have been the cause
for maintaining intravenous antimicrobial treatment in most
cases.
Although the duration of the intravenous antimicrobial
therapy decreased by one day, the reduction was not signif-
icant. However, as the criteria for switching to oral therapy
or discontinuing the treatment were only evaluated in the IP,
it was not possible to assess the effect of the intervention
on the duration of intravenous antimicrobial therapy just in
patients who met  the criteria. Thus, the effect of the interven-
tion on the duration of intravenous antimicrobial treatment
was diluted since the analysis also included patients who  did
not meet the criteria, which was a limitation of the study.
While one might think that the good results of interven-
tions evaluated in other studies are due to the fact that they
were carried on more  developed countries, with more  orga-
nized healthcare facilities van Niekerk et al.31 demonstrated
that despite facing difﬁculties, interventions in a developing
country have led to an increased number of patients who  had
intravenous therapy switched to oral therapy, rising from 16%
to 43.9%. There was also a decrease in the duration of the intra-
venous therapy and costs. This probably occurred because
feedback to physicians and direct attempt to convince them
to change the therapy were also part of the intervention.31
Although the two study periods occurred in different
months of the year, allowing for possible seasonal bias, the
demographic and clinical characteristics found were sim-
ilar among the populations studied in the two  different
periods.
As noted in other studies in which interventions to reduce
the duration of intravenous antimicrobial therapy was suc-
cessful, we  also observed no indication that there was any
interference with the effectiveness of the treatment and
patient safety.23,24,26 There was no difference between the
two periods regarding the frequency of resuming intravenous
antimicrobial treatment and mortality. In this context, the
detected increase in the global percentage of readmissions in
the IP could indicate a harmful effect of the intervention. How-
ever, when we analyze the percentage related only to the group
of patients who switched to oral therapy, or who  had antimi-
crobial treatment stopped, there was no signiﬁcant difference.
Then, the global increase probably occurred for reasons other
than the intervention itself. We do not have enough data to
explain the reason for such global increase.
The difference found in both periods regarding commonly
used antimicrobial classes may be due to episodes of shortage
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of some antimicrobials, which occurred in both study periods.
However, there was no lack of antimicrobials used orally in
neither of the periods.
The signiﬁcant result of this study contrasts with a previ-
ous study carried out in the same hospital, in which strategies
involving preparation, presentation and distribution of guide-
lines, and daily reminders to physicians through labels afﬁxed
on non computerized prescriptions turned out ineffective.29
The difference is probably due to the use of computerized
features in the present study that delivered the messages at
the time the prescription were prepared and, above all, due
to prescription suspension, which required physicians to ﬁll
in the justiﬁcation for continued use of intravenous antimi-
crobials. These resources have been successfully used for the
appropriateness of antimicrobials use.14,32
It must be considered that, despite the modest beneﬁt of
the intervention evaluated in this study, its implementation in
places where the prescription system is similar, is simple and
comes at a low cost. Other studies may test this intervention
with some modiﬁcations. As this intervention was interrupted
with the physician’s justiﬁcation, one could argue whether it
would be more  effective if the justiﬁcation was assessed and if
it was not convincing there should be an attempt to persuade
the physician in charge. Perhaps a direct contact with the
prescribers would produce even more  signiﬁcant outcomes.
However, this study was looking for an effective, inexpensive,
and easy to maintain strategy.
As long as computerization already exists, the proposed
intervention can be easily implemented and enforced by the
pharmacist in daily practice with good acceptance by physi-
cians. A recent acknowledgment by Cochrane recognized that
due to the complexity of healthcare organizations, individual
hospitals will always have to evaluate their own interventions
and that multi-faceted and complex interventions are not nec-
essarily more  effective than simple interventions.33
Conclusion
We  conclude that the intervention carried out in this study
is effective with regard to the early discontinuation of intra-
venous antibiotics and/or switch to oral therapy. Although
this conclusion is not necessarily valid for all types of
hospitals, this study suggests it is worthwhile at least
testing the evaluated strategy in hospitals that wish to
deploy some intervention toward that end. The cost/beneﬁt
ratio of the intervention should be ascertained, including
whether computerization and/or appropriateness of the pre-
scription system already exists or whether they are still
necessary.
Other approaches related to the rational use of antimi-
crobial agents can also be added to the intervention as well
as feedback to physicians for appropriateness of antimicro-
bial therapy. This study indicates that despite the difﬁculties
faced in developing countries, pharmacists can contribute to
an improvement in the use of antimicrobials in hospitals, and
simple interventions such as the one proposed here are of low
cost and easy to implement, which is especially important
with regard to their maintenance and sustainability.
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